| Novak, J., Rizk, D., Takahashi, K., Zhang, X., Bian, Q., Ueda H., Ueda, Y., Reily, C., Lai, L.-Y., Hao, C., Novak, L., Huang, Z.-Q., Renfrow M.B., Suzuki, H., Julian, B.A. New insights into the pathogenesis of IgA nephropathy. Kidney Dis. 1, 8-18, 2015. |
|
| Dennis, E.A., Coats, M.T., Griffin, S.E., Hale, J.Y., Novak, L., Briles, D.E., and Crain, M.J. The effects of CFTR and mucoid phenotype on susceptibility and innate immune responses in a mouse model of pneumococcal lung disease. PloS one. 10(10):e0140335, 2015. |
|
| Walker, M.M., Novak, L., Widener, R., Grubbs, J.A., King, J., Hale, J.Y., Ochs, M.M., Briles, D.E., Deshane, J. PcpA promotes higher levels of infection and modulates recruitment of myeloid-derived suppressor cells during pneumococcal pneumonia. J. Immunol. 196, 2239-2248, 2016. |
|
| Friedland, B.A., Hoesley, C.C., Plagianos, M.G., Hoskin, E., Zhang, S.; Teleshova, N., Alami, M., Kleinbeck, K., Katzen, L., Thomas M. Zydowsky, T.M., Novak, L., Fernández-Romero, J.A., Creasy, G. A First-in-Human Trial of MIV-150 and Zinc Acetate Co-Formulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence and Pharmacodynamics. J. Acquir. Immune Defic. Syndr. 73, 489-496, 2016. |
|
| Toboni, M.D., Smith, H.J., Dilley, SE., Novak, L., Leath, C.A. Malignant Brenner tumor associated with a germline BRCA2 mutation. Gynecol Oncol Rep. 21:17-19, 2017. |
|
|